Cargando…
A structured group exercise program for patients with metastatic cancer receiving chemotherapy and CTNNB1 (β-catenin) as a biomarker of exercise efficacy
INTRODUCTION: Exercise can improve the symptoms of cancer. However, is it a cancer treatment? We tested the feasibility of group exercise for metastatic cancer patients while on chemotherapy. A biomarker for exercise efficacy in colorectal cancer (CRC), β-catenin, was tested. METHODS: Patients under...
Autores principales: | Chiarotto, James A, Akbarali, Riyad, Bellotti, Lara, Dranitsaris, George |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5648300/ https://www.ncbi.nlm.nih.gov/pubmed/29075139 http://dx.doi.org/10.2147/CMAR.S147054 |
Ejemplares similares
-
PROP1 and CTNNB1 expression in adamantinomatous craniopharyngiomas with or without β-catenin mutations
por: Cani, Carolina M.G., et al.
Publicado: (2011) -
A Community Hospital-Based Study: A Prespecified Neutrophil Count with Adjuvant mFOLFOX6 Associated with Increased Delays, Increased G-CSF Use, and Reduced Dose Intensity
por: Chiarotto, James A, et al.
Publicado: (2021) -
Slit2 as a β-catenin/Ctnnb1-dependent retrograde signal for presynaptic differentiation
por: Wu, Haitao, et al.
Publicado: (2015) -
Nuclear β-Catenin Localization and Mutation of the CTNNB1 Gene: A Context-Dependent Association
por: Kim, Grace, et al.
Publicado: (2018) -
Trichoblastic carcinosarcoma with panfollicular differentiation (panfollicular carcinosarcoma) and CTNNB1 (beta‐catenin) mutation
por: Giang, Jenny, et al.
Publicado: (2020)